results of the company’s TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in “Nature – Scientific Reports” in a paper titled “Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial.”